Inventor · disambiguated record
Jiayao Li
Also filed as: LI JIAYAO
26 granted patents·21 pending applications·145 citations·filing 2001–2025
96Inventor score
Files withGILEAD SCIENCES INC34AXYS PHARM INC6NETEASE HANGZHOU NETWORK CO LTD2AVENTIS PHARMA INC1AVENTIS PHARMA SA1
Top patents by PatentIndex Score
47 records- 0198US11753399B2Therapeutic compoundsGILEAD SCIENCES INC·Filed 2022·Granted Sep 12, 2023·7 cites·31 claims
- 0298US10947259B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2020·Granted Mar 16, 2021·11 cites·4 claims
- 0397US11613546B2Substituted pyridotriazine compounds and uses thereofGILEAD SCIENCES INC·Filed 2022·Granted Mar 28, 2023·9 cites·44 claims
- 0497US11548902B1Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical useGILEAD SCIENCES INC·Filed 2021·Granted Jan 10, 2023·7 cites·60 claims
- 0597US11325930B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2021·Granted May 10, 2022·8 cites·4 claims
- 0697US11267801B2Therapeutic compoundsGILEAD SCIENCES INC·Filed 2020·Granted Mar 8, 2022·4 cites·23 claims
- 0797US11084832B2Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical useGILEAD SCIENCES INC·Filed 2020·Granted Aug 10, 2021·25 cites·47 claims
- 0896US11897892B2Substituted pyridotriazine compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Feb 13, 2024·6 cites·35 claims
- 0996US10836746B2Therapeutic compoundsGILEAD SCIENCES INC·Filed 2019·Granted Nov 17, 2020·20 cites·26 claims
- 1095US12024528B2Bridged tricyclic carbamoylpyridone compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Jul 2, 2024·6 cites·28 claims
- 1193US12187734B2Substituted pyridotriazine compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Jan 7, 2025·1 cites·27 claims
- 1293US12054496B2Bridged tricyclic carbamoylpyridone compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Granted Aug 6, 2024·2 cites·30 claims
- 1392US12404262B2Therapeutic compounds for HIV virus infectionGILEAD SCIENCES INC·Filed 2022·Granted Sep 2, 2025·1 cites·22 claims
- 1491US9376441B2Substituted pyrrolidines as SYK inhibitorsGILEAD SCIENCES INC·Filed 2014·Granted Jun 28, 2016·17 cites·20 claims
- 1589US12398160B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2023·Granted Aug 26, 2025·0 cites·2 claims
- 1688US2025333428A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 1785US2025188089A1Substituted pyridotriazine compounds and uses thereofGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1884US2025179102A1Therapeutics compounds for hiv virus infectionGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1983US11827662B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2022·Granted Nov 28, 2023·0 cites·2 claims
- 2083US10442804B2Compounds for the treatment of hepatitis B virus infectionGILEAD SCIENCES INC·Filed 2018·Granted Oct 15, 2019·4 cites·20 claims
- 2183US10005774B2Syk inhibitorsGILEAD SCIENCES INC·Filed 2016·Granted Jun 26, 2018·4 cites·9 claims
- 2283US2025115619A1Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical useGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2382US12227520B2Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical useGILEAD SCIENCES INC·Filed 2022·Granted Feb 18, 2025·0 cites·8 claims
- 2482US7737300B2Processes and intermediates preparing cysteine protease inhibitorsVIROBAY INC·Filed 2005·Granted Jun 15, 2010·4 cites·1 claims
- 2582US2024067629A1Therapeutic compoundsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 2678US2024246975A1Bridged tricyclic carbamoylpyridone compounds and uses thereofGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 2775US2025115620A1Bridged tricyclic carbamoylpyridone compounds and uses thereofGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2873US2021061831A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2020·Application pending·0 cites
- 2973US2022259234A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2020·Application pending·0 cites
- 3072US12421235B2Bridged tricyclic carbamoylpyridone compounds and uses thereofGILEAD SCIENCES INC·Filed 2021·Granted Sep 23, 2025·0 cites·22 claims
- 3172US7998950B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2009·Granted Aug 16, 2011·1 cites·17 claims
- 3269US2025120989A1Bridged tricyclic carbamoylpyridone compounds and uses thereofGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3369US2025127801A1Bridged tricyclic carbamoylpyridone compounds and uses thereofGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3468US2025122219A1Bridged tricyclic carbamoylpyridone compounds and uses thereofGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3567US7091360B2Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses thereofAVENTIS PHARMA SA·Filed 2003·Granted Aug 15, 2006·3 cites·7 claims
- 3667US7064123B1Compounds and compositions as cathepsin inhibitorsAXYS PHARM INC·Filed 2001·Granted Jun 20, 2006·4 cites·22 claims
- 3762US7030116B2Compounds and compositions as cathepsin inhibitorsAXYS PHARM INC·Filed 2002·Granted Apr 18, 2006·1 cites·9 claims
- 3857US12268961B2Positioning method and device for game and mobile terminalNETEASE HANGZHOU NETWORK CO LTD·Filed 2021·Granted Apr 8, 2025·0 cites·19 claims
- 3956US2006135781A1Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses thereofAXYS PHARM INC·Filed 2006·Application pending·0 cites
- 4050US2007049594A1Novel compounds and compositions as cathepsin inhibitorsAXYS PHARM INC·Filed 2005·Application pending·0 cites
- 4150US2009291921A1Integrase inhibitorsGILEAD SCIENCES INC·Filed 2008·Application pending·0 cites
- 4250US2006089357A1Novel compounds and compositions as cathepsin inhibitorsAXYS PHARM INC·Filed 2005·Application pending·0 cites
- 4348US2007105892A1Amidino compounds as cysteine protease inhibitorsAXYS PHARM INC·Filed 2004·Application pending·0 cites
- 4444US2004142999A1Novel compounds and compositions as cathepsin inhibitorsAVENTIS PHARMA INC·Filed 2003·Application pending·0 cites
- 4543US2013338142A1Imidazopyrazine syk inhibitorsGILEAD CONNECTICUT INC·Filed 2013·Application pending·0 cites
- 4642US2024318722A1Rubber sealing gasket with excellent compression performance and low-temperature performance, and preparation method and use thereofXUZHOU COLLEGE IND TECHNOLOGY·Filed 2024·Application pending·0 cites
- 4742US2024252920A1Method and apparatus for displaying game interface, and device and storage medium thereofNETEASE HANGZHOU NETWORK CO LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jiayao Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →